doi: 10.3389/fnmol.2025.1549366 Received 21 December 2024 Accepted 12 March 2025 Published 07 April 2025 Volume 18 - 2025 Edited by Inigo Ruiz de Azua, Johannes Gutenberg University Mainz, Germany Reviewed by Beatrice Ferrari, San Matteo Hospital Foundation (IRCCS), Italy Ken-ichiro Nakajima, Nagoya University, Japan Keisuke Ito, University of Shizuoka, Japan Updates Copyright 2025 Shiimura, Kojima and Sato
NAD may support metabolic health and energy levels, which can complement weight loss and wellness programs when combined with lifestyle guidance
If the GLP-1/GIP/glucagon receptor class shows disease-modifying behaviour in OA rather than just mechanical pain relief from weight loss, it expands the scientific rationale for the compound and reinforces the argument that the triple-agonist mechanism is doing more than suppressing appetite
The Wolverine Stack at Perfect B uses separate injections at separate sites, timed according to the protocol prescribed by the APRN at intake
Camille et al., 2021)